Time to Metastasis May Be a Surrogate for UTUC Survival After Surgery
Distant metastasis emerged as the best candidate to be a surrogate endpoint for survival among patients receiving surgical treatment for upper tract urothelial carcinoma.
Urothelial Cancer
Cutaneous Adverse Effects Common With Enfortumab Vedotin for Urothelial Cancer
Researchers described dermatologic events associated with the use of enfortumab vedotin in treatment of locally advanced/metastatic urothelial cancer.
- Loading...
Loading...
Next post in Bladder Cancer
Loading... 
Loading...